TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
WuXi AppTec Co., Ltd. Class H ( (HK:2359) ) has issued an update.
WuXi AppTec Co., Ltd. has announced that its board of directors will convene on October 24, 2025, to review and approve the company’s third-quarter financial results for the period ending September 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (HK:2359) stock is a Buy with a HK$106.00 price target. To see the full list of analyst forecasts on WuXi AppTec Co., Ltd. Class H stock, see the HK:2359 Stock Forecast page.
More about WuXi AppTec Co., Ltd. Class H
WuXi AppTec Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical and biotechnology industry. The company, along with its subsidiaries, focuses on providing comprehensive laboratory and manufacturing services to support the pharmaceutical, biotech, and medical device industries globally.
Average Trading Volume: 9,387,392
Technical Sentiment Signal: Buy
Current Market Cap: HK$354.3B
For detailed information about 2359 stock, go to TipRanks’ Stock Analysis page.